---
figid: PMC7281157__marinedrugs-18-00242-g003
figtitle: Fucoidan on liver injury
organisms:
- Saccharomyces cerevisiae
- PX clade
- Saccharina japonica
- Undaria pinnatifida
- Fucus vesiculosus
- Ecklonia cava
- Ascophyllum nodosum
- Sargassum polycystum
- Cladosiphon okamuranus
- Costaria costata
- Neopyropia tenera
- Turbinaria decurrens
- Saccharina sculpera
- Sargassum fluitans
- Porphyra sp.
- Papenfussiella lutea
- Splachnidium rugosum
- Scytothamnus australis
- Human immunodeficiency virus 1
- Adenoviridae
- Influenza A virus
- Coronaviridae
- Human alphaherpesvirus 1
- Human immunodeficiency virus
- Human betaherpesvirus 5
- H1N1 subtype
- Human alphaherpesvirus 2
- Dengue virus type 2
- Bovine viral diarrhea virus 1
- Human respirovirus 1
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- prion
- Streptococcus pneumoniae
- Eimeria maxima
pmcid: PMC7281157
filename: marinedrugs-18-00242-g003.jpg
figlink: pmc/articles/PMC7281157/figure/marinedrugs-18-00242-f003/
number: F3
caption: Effects of fucoidan on liver injury. Damaging agents at the top left side,
  APAP and carbon tetrachloride (CCl4), and protective fucoidan at the top right side.
  Fucoidan averts liver fibrosis by inhibiting HSCs production through optimal synthesis
  of collagen and alpha smooth muscle actin and prevents tissue damage by reducing
  transaminase release and restoring antioxidant potentials of cells. It decreases
  CYP2E1 activity, which reduces levels of toxic metabolites and inhibits TGF-β/Smad
  pathway, thereby hindering the occurrence of autophagosomes. Fucoidan also stimulates
  expression of sirtuin-1 in the liver, which activates AMPK and alleviates insulin
  resistance.
papertitle: Potential Beneficial Actions of Fucoidan in Brain and Liver Injury, Disease,
  and Intoxication—Potential Implication of Sirtuins.
reftext: Jasmina Dimitrova-Shumkovska, et al. Mar Drugs. 2020 May;18(5):242.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8880674
figid_alias: PMC7281157__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Bos taurus
redirect_from: /figures/PMC7281157__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7281157__marinedrugs-18-00242-g003.html
  '@type': Dataset
  description: Effects of fucoidan on liver injury. Damaging agents at the top left
    side, APAP and carbon tetrachloride (CCl4), and protective fucoidan at the top
    right side. Fucoidan averts liver fibrosis by inhibiting HSCs production through
    optimal synthesis of collagen and alpha smooth muscle actin and prevents tissue
    damage by reducing transaminase release and restoring antioxidant potentials of
    cells. It decreases CYP2E1 activity, which reduces levels of toxic metabolites
    and inhibits TGF-β/Smad pathway, thereby hindering the occurrence of autophagosomes.
    Fucoidan also stimulates expression of sirtuin-1 in the liver, which activates
    AMPK and alleviates insulin resistance.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Hc
  - ci
  - oh
  - soo
  - Gpt
  - Tmprss11d
  - Slc17a5
  - Il6
  - Tnf
  - Tgfb1
  - Ltbp1
  - Acta2
  - Nfe2l2
  - Sod2
  - mn
  - Cat
  - cac
  - Mip
  - Trpv6
  - Glyat
  - Foxo3
  - IL6
  - TNF
  - LDH
  - NFE2L2
  - SOD2
  - CAT
  - Cl-C
  - Glu
  - GSH
  - Mn
---
